The Evaluation of Gut Microbiota in Obese Children with Primary Hypertension

Ece Senbaykal Yigit1, Hörü Gazi2, Pelin Ertan3

  • 1Department of Pediatrics, Manisa Celal Bayar University, Manisa, Turkey.

Klinische Padiatrie
|August 11, 2025
PubMed

Insights

Children with hypertension show reduced gut microbial richness and altered bacterial levels, particularly a higher Firmicutes/Bacteroidetes ratio. These gut dysbiosis findings may lead to new diagnostics and treatments for childhood hypertension.

Area of Science:

  • Microbiology
  • Pediatric Health
  • Gastroenterology

Background:

  • Childhood hypertension prevalence is rising.
  • Gut microbiota dysbiosis is increasingly linked to hypertension.
  • Understanding gut microbiome alterations in pediatric hypertension is crucial.

Purpose of the Study:

  • To compare gut microbiota composition in children with primary hypertension versus normotensive controls.
  • To identify specific microbial differences associated with childhood hypertension.
  • To explore potential diagnostic and therapeutic targets related to the gut microbiome.

Main Methods:

  • Case-control study design with 20 hypertensive and 20 normotensive children.
  • Exclusion of participants with chronic diseases, recent antibiotic use, or active infection.
  • 16S rRNA sequencing of stool samples for microbial analysis.

Main Results:

  • Significantly reduced microbial richness at all taxonomic levels in hypertensive children.
  • No significant differences in alpha and beta diversity indices between groups.
  • Lower levels of Bacteroidetes and Firmicutes, with an increased Firmicutes/Bacteroidetes ratio in hypertensive patients (p<0.05).

Conclusions:

  • Children with hypertension exhibit distinct gut microbiota dysbiosis.
  • Findings suggest the gut microbiome as a potential biomarker and therapeutic target for childhood hypertension.
  • This research opens avenues for microbiota-based diagnostics and personalized preventive strategies.